StonvexLoading…
StonvexStonvexStonvexCore line items from CRNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $338.73M | $394.19M | $347.18M | $295.17M |
Operating Income | $7.25M | $38.73M | $21.21M | $-10.94M |
Net Income | $-2.09M | $24.06M | $6.22M | $-19.69M |
EPS (Diluted) | $-0.02 | $0.27 | $0.07 | $-0.23 |
Total Assets | $317.04M | $345.00M | $298.52M | $289.32M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $38.37M | $35.31M | $28.24M | $22.95M |
Free Cash Flow OCF − CapEx | $17.95M | $11.62M | $20.93M | $-15.36M |
Shares Outstanding | 90.63M | 88.39M | 85.42M | 84.35M |